+

WO1999031253A3 - Nouvelles molecules d'acide nucleique et proteines d'epoxyde hydrolase de puces, et leurs utilisations - Google Patents

Nouvelles molecules d'acide nucleique et proteines d'epoxyde hydrolase de puces, et leurs utilisations Download PDF

Info

Publication number
WO1999031253A3
WO1999031253A3 PCT/US1998/026359 US9826359W WO9931253A3 WO 1999031253 A3 WO1999031253 A3 WO 1999031253A3 US 9826359 W US9826359 W US 9826359W WO 9931253 A3 WO9931253 A3 WO 9931253A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
epoxide hydrolase
nucleic acid
acid molecules
arthropod
Prior art date
Application number
PCT/US1998/026359
Other languages
English (en)
Other versions
WO1999031253A2 (fr
Inventor
Nancy Wisnewski
Gary M Silver
Katherine C Lo
Kevin S Brandt
Original Assignee
Heska Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heska Corp filed Critical Heska Corp
Priority to AU18183/99A priority Critical patent/AU1818399A/en
Publication of WO1999031253A2 publication Critical patent/WO1999031253A2/fr
Publication of WO1999031253A3 publication Critical patent/WO1999031253A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne des protéines d'époxyde hydrolase d'arthropodes; des molécules d'acide nucléique d'époxyde hydrolase d'arthropodes, y compris celles codant les protéines d'époxyde hydrolase; des anticorps contre ces protéines d'époxyde hydrolase; et d'autres composés inhibant l'activité d'époxyde hydrolase d'arthropodes. La présente invention concerne également des méthodes de production de ces protéines, des molécules d'acide nucléique, des anticorps et des composés d'inhibition. L'invention concerne en outre des compositions thérapeutiques comprenant ces protéines, les molécules d'acide nucléique, les anticorps et/ou les composés d'inhibition ainsi que l'utilisation de ces compositions thérapeutiques pour protéger des animaux contre une infestation par des arthropodes hématophages.
PCT/US1998/026359 1997-12-12 1998-12-10 Nouvelles molecules d'acide nucleique et proteines d'epoxyde hydrolase de puces, et leurs utilisations WO1999031253A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU18183/99A AU1818399A (en) 1997-12-12 1998-12-10 Novel flea epoxide hydrolase nucleic acid molecules, proteins and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/989,510 1997-12-12
US08/989,510 US6037160A (en) 1997-12-12 1997-12-12 Flea epoxide hydrolase nucleic acid molecules, proteins and uses thereof

Publications (2)

Publication Number Publication Date
WO1999031253A2 WO1999031253A2 (fr) 1999-06-24
WO1999031253A3 true WO1999031253A3 (fr) 1999-09-16

Family

ID=25535175

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/026359 WO1999031253A2 (fr) 1997-12-12 1998-12-10 Nouvelles molecules d'acide nucleique et proteines d'epoxyde hydrolase de puces, et leurs utilisations

Country Status (5)

Country Link
US (4) US6037160A (fr)
AR (1) AR013801A1 (fr)
AU (1) AU1818399A (fr)
WO (1) WO1999031253A2 (fr)
ZA (1) ZA9811354B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6891085B2 (en) * 2001-04-20 2005-05-10 Pioneer Hi-Bred International, Inc. Nucleic acid encoding the FUS6 antimicrobial polypeptide of Agrotis ipsilon and its use to enhance disease resistance in a plant
US7612194B2 (en) 2001-07-24 2009-11-03 Monsanto Technology Llc Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
US6943001B2 (en) * 2001-08-03 2005-09-13 Diversa Corporation Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
EP1578987A2 (fr) * 2001-08-03 2005-09-28 Diversa Corporation Epoxyde-hydrolases, acides nucleiques codant ces hydrolases et procedes de fabrication et d'utilisation de celles-ci
NZ533657A (en) * 2002-01-03 2008-01-31 Smithkline Beecham Corp Methods for the preparation of immunoconjugates, in particular maytansinoids conjugated to a monoclonal antibody
ES2547381T3 (es) 2004-04-09 2015-10-05 Monsanto Technology, Llc Composiciones y procedimientos de control de infestaciones de insectos en plantas
EP3508582B1 (fr) 2005-09-16 2021-01-13 Monsanto Technology LLC Procédés de contrôle génétique d'infestation d'insectes dans des plantes et compositions correspondantes
EP3877519A4 (fr) 2018-11-09 2022-08-24 Ginkgo Bioworks, Inc. Biosynthèse de mogrosides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0516590A1 (fr) * 1991-05-31 1992-12-02 Sandoz Ltd. Méthode de lutte contre les puces
US5445956A (en) * 1993-08-13 1995-08-29 The Regents Of The University Of California Recombinant soluble epoxide hydrolase

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0516590A1 (fr) * 1991-05-31 1992-12-02 Sandoz Ltd. Méthode de lutte contre les puces
US5445956A (en) * 1993-08-13 1995-08-29 The Regents Of The University Of California Recombinant soluble epoxide hydrolase

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JACOBSON M ET AL.: "Juvenile hormone activity of a variety of structural types against several insect species", INSECT JUVENILE HORMONES; CHEMISTRY AND ACTION, ACADEMIC PRESS (MENN J J AND BEROZA M EDS.), 1972, New York, pages 249 - 302, XP002109651 *
TAKIGAWA T ET AL.: "Synthesis of the thiirane analogs of juvenile hormone III and other juvenile hormone mimics", AGRICULTURAL AND BIOLOGICAL CHEMISTRY, vol. 43, no. 7, July 1979 (1979-07-01), pages 1591 - 1594, XP002109652 *
TOUHARA K AND PRESTWICH G D: "Juvenile hormone epoxide hydrolase", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 26, 15 September 1993 (1993-09-15), pages 19604 - 19609, XP002099927 *
WOJTASEK H AND PRESTWICH G D: "An insect juvenile hormone-specific epoxide hydrolase is related to vertebrate microsomal epoxide hydrolases", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 220, no. 2, March 1996 (1996-03-01), pages 323 - 329, XP002099926 *

Also Published As

Publication number Publication date
ZA9811354B (en) 1999-06-10
US6153397A (en) 2000-11-28
US6290958B1 (en) 2001-09-18
AU1818399A (en) 1999-07-05
US6143542A (en) 2000-11-07
US6037160A (en) 2000-03-14
WO1999031253A2 (fr) 1999-06-24
AR013801A1 (es) 2001-01-10

Similar Documents

Publication Publication Date Title
WO2002012501A3 (fr) Anticorps anti-integrines doubles, compositions, procedes et utilisations associes
WO2002097048A3 (fr) Proteines derivees de l'immunoglobuline anti-p40, compositions, procedes et utilisations
WO2005005604A3 (fr) Proteines derivees de l'immunoglobuline anti-cible et genetiquement modifiees, compositions, procedes et utilisations
WO2004003147A3 (fr) Polypeptides cngh0004, anticorps, compositions, procedes et utilisations
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
CA2418961A1 (fr) Anticorps, compositions, procedes anti-il-12 et leur utilisation
WO2002095055A3 (fr) Compositions et methodes destinees a etre utilisees pour isoler des molecules d'acide nucleique
WO1998041513A3 (fr) Amides d'acide aminosalicylique substitues a effet fongicide et produits intermediaires pour leur preparation
WO2003030821A3 (fr) Proteines de fusion d'albumine
WO2000061621A3 (fr) Molecules d'acides nucleiques et proteines issues de la tete, de la moelle epiniere, de l'intestin posterieur et du tube de malpighi de puces et utilisations correspondantes
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO1999031253A3 (fr) Nouvelles molecules d'acide nucleique et proteines d'epoxyde hydrolase de puces, et leurs utilisations
WO2001040313A3 (fr) Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations
WO2004067567A3 (fr) Anticorps diriges contre le virus dengue, compositions, methodes et utilisations correspondantes
AR010565A1 (es) Moleculas de acido nucleico aislados, proteina aislada, formulaciones que las contienen, composicion terapeutica, uso de un compuesto protector y uninhibidor para preparar una composicion terapeutica, metodo para producir una proteina de carboxilesterosa, metodo para identificar compuestos, equipo d
WO2002062304A3 (fr) Agents cosmetiques et/ou pharmaceutiques
WO1999047558A3 (fr) Nouvelles formes de protèines de co-stimulation des lymphocytes t, molècules d'acide nuclèique et leur utilisation
MX9702776A (es) Proteinas de proteasa de pulgas, moleculas de acido nucleico, y usos de las mismas.
WO1999002704A3 (fr) Phosphatase a double specificite et procedes d'utilisation
WO2000040232A3 (fr) Nouvelles compositions et trousses de bretylium, et leur utilisation dans la prevention et le traitement des pathologies cardio-vasculaires
WO1998020034A3 (fr) Nouvelles molecules d'acide nucleique inhibant la serine protease, proteine inhibant la serine protease, et leurs utilisations
WO2003057821A3 (fr) Proteines et anticorps mut-il-18 or mut-il-18r, compositions, procedes et utilisations
DE69732857D1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
WO2003102017A3 (fr) Anticorps diriges contre la fusion de la proteine de type reg, compositions, procedes et utilisations
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载